Answers
#1 in Business Subscribe Email Print

You are here: Home > Finance > Investing > Investment Strategies – Choosing Between the Specialist and the Generalist

Tags

  • confident
  • successful
  • generalist
  • developing combination
  • developing combination
  • developing combination

  • Links

  • Online Dating
  • View Albuquerque's Melon Sunsets from Sandia Peak Tramway
  • Closet Organizers - Ending Your Storage Nightmare
  • Answers - Investment Strategies – Choosing Between the Specialist and the Generalist

    It is common knowledge that in business you need to focus. How would this -- focus -- relate to different investment stra
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    tegies?

    To grow into a successful stock trader you do not need an academic background, although it might help. Imagine
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    that you start concentrating on one stock, for example an oil company. This is not the easiest choice, but it fits the se
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ting of the example.

    You start with a blank slate and before you invest any amount of money you learn all about the comp
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    any, the financial statements or just all the technical analysis about the specific stock. If you are not confident with
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    echnical analysis you can trust on the free technical signals provided by many providers. All you need to know is when th
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    e signal communicates a buy, a hold or a sell.

    Then you should learn about investment strategies. But the simplest one i
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    just buying and selling the stock. You could elaborate this by buying and selling options, futures, selling short (stock
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    s you do not own), but all these do not matter in tuning your investment strategy.

    If you are confident enough you can s
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    art trading this way. At one moment in time, your portfolio will consist of this stock but in different occurrences; a nu
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    mber of stocks itself, a corporate bond of the oil company, call or put options on the same stock, or even a specialized
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    oil mutual fund. If you follow this strategy you have a limited but balanced portfolio (balanced in the time, rather tha
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    in different investments). Your strategy consists of beating the market for this hyper narrow investment category: oil.
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin

    At the other end of the available strategic choices you will find the possibility to invest like a generalist. In this c
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    se (for those who start the investment game) you should learn also about the different investment instruments, like stock
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    s, bonds, options, etc. But then, the strategy is different. Rather than focusing on one stock or company you are indiffe
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ent to companies, sectors, or even currencies. You balance your portfolio with different instruments in the way it best s
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    uits your investment profile. You may do this in an autonomous way, or with the help of a financial advisor, buying a sin
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    le mutual fund.

    It is clear that what you win in the specialist case you loose in the generalist option; the more your f
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ocus on one specialization, the more you loose on (other) market opportunities.

    As it is in business...

    © 2006 Hans Boo


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.answers.org.ua/article/103780/answers-Investment-Strategies--Choosing-Between-the-Specialist-and-the-Generalist.html">Investment Strategies – Choosing Between the Specialist and the Generalist</a>

    BB link (for phorums):
    [url=http://www.answers.org.ua/article/103780/answers-Investment-Strategies--Choosing-Between-the-Specialist-and-the-Generalist.html]Investment Strategies – Choosing Between the Specialist and the Generalist[/url]

    Related Articles:

    IT Consulting Services: 3 Factors For Choosing What to Offer

    Work Place Communication in Trucking with Dispatchers

    Obtain a Merchant Account and Start To Accept Credit Cards Online

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com